7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      DDAB cationic lipid-mPEG, PCL copolymer hybrid nano-carrier synthesis and application for delivery of siRNA targeting IGF-1R into breast cancer cells

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Exploring the full spectrum of macrophage activation.

          Macrophages display remarkable plasticity and can change their physiology in response to environmental cues. These changes can give rise to different populations of cells with distinct functions. In this Review we suggest a new grouping of macrophage populations based on three different homeostatic activities - host defence, wound healing and immune regulation. We propose that similarly to primary colours, these three basic macrophage populations can blend into various other 'shades' of activation. We characterize each population and provide examples of macrophages from specific disease states that have the characteristics of one or more of these populations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nanocarriers as an emerging platform for cancer therapy.

            Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Nanoparticles in medicine: therapeutic applications and developments.

              Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.
                Bookmark

                Author and article information

                Contributors
                Journal
                Clinical and Translational Oncology
                Clin Transl Oncol
                Springer Science and Business Media LLC
                1699-048X
                1699-3055
                June 2021
                January 03 2021
                June 2021
                : 23
                : 6
                : 1167-1178
                Article
                10.1007/s12094-020-02507-3
                03afeb93-fc03-4b14-b335-741af472f61d
                © 2021

                https://www.springer.com/tdm

                https://www.springer.com/tdm

                History

                Comments

                Comment on this article